Multimodal treatment disparities in pancreatic cancer significantly affect patient survival and care.

• 8,466 patients analyzed; nonmetastatic cases had higher therapy rates than metastatic.
• Non-Hispanic black patients experienced longer delays to treatment compared to non-Hispanic whites.
• Uninsured and Medicaid patients showed the highest odds of not receiving therapy in metastatic cases.

Primary resection strongly predicts improved survival outcomes. Addressing these disparities is critical for enhancing patient care strategies.